Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Anesth Pain Med ; 13(3): e136423, 2023 Jun.
Article in English | MEDLINE | ID: mdl-38021328

ABSTRACT

Context: Hemiplegic shoulder pain (HSP) is one of the complications of a stroke. Objectives: This study aimed to determine shoulder pain prevalence in cerebrovascular accident (CVA) patients. Methods: This meta-analysis study searched English and Persian descriptive or descriptive-analytical full-text studies on CVA patients. The search was carried out in all databases by two researchers using keywords such as stroke, pain, CVA, hemiplegic, and shoulder pain. Data analysis was done with the software CMA3. Results: In the initial search, 109 articles were found, and finally, the data from four articles were analyzed. The prevalence of HSP was 23% (confidence interval (CI) = 10.3% - 43.5%). Conclusions: Considering the HSP prevalence (28.1%) among CVA patients, it is necessary to carry out rehabilitation interventions to prevent such pain in these patients. It is also suggested that rehabilitation interventions be included in the patient education of the healthcare system.

2.
Hosp Top ; 101(2): 65-72, 2023.
Article in English | MEDLINE | ID: mdl-34445942

ABSTRACT

INTRODUCTION: The possibility of surface transmission in hospitals with high density of COVID- 19 patients is unneglectable. The aim of this study is to determine the extent of surface contamination in coronavirus central hospital of Ilam province in western Iran. MATERIALS AND METHODS: In this experimental study, 205 samples were taken from environmental surfaces in hospital. SARS-CoV-2 RNA detected by Real-time RT-PCR. RESULTS: 121 out of 205 (50.02%) samples were positive. The most contaminated objects were toilet sites (5/5,100% ICU; 5/5, 100% isolation wards). CONCLUSION: High surface contamination with SARS-CoV-2 proposes the surface as a potential route of transmission.


Subject(s)
Bathroom Equipment , COVID-19 , Humans , SARS-CoV-2 , RNA, Viral , Hospitals
3.
Infect Disord Drug Targets ; 21(8): e211221191975, 2021.
Article in English | MEDLINE | ID: mdl-33653256

ABSTRACT

INTRODUCTION: COVID-19 has caused a great deal of fear in different communities. In this study, we reported the recovery of a diabetic elderly woman with a history of asthma from COVID-19 infection. CASE PRESENTATION: A 61-year-old woman was hospitalized due to dyspnea and low blood O2 saturation and was later diagnosed with COVID-19, as confirmed by PCR. The patient had a history of asthma and diabetes and used salbutamol and Atrovent spray. She also had a history of hospitalization at one month prior to the current admission. Despite all these, COVID-19 was successfully managed, and she was discharged with a good clinical condition after the improvement of respiratory complications. CONCLUSION: Despite having an advanced age and underlying diseases (diabetes and asthma), the recovery of this elderly woman shows that even such patientscandefeatCOVID-19 as long as the disease is not progressed to advanced phases and appropriate therapeutic measures are taken. By reporting such cases, it is possible to give people hope and motivation and reduce their fear of the disease.


Subject(s)
Asthma , COVID-19 , Diabetes Mellitus , Aged , Asthma/complications , Asthma/drug therapy , Female , Hospitalization , Humans , Middle Aged , SARS-CoV-2
4.
Sci Total Environ ; 748: 141324, 2020 Dec 15.
Article in English | MEDLINE | ID: mdl-32805566

ABSTRACT

On December 31, 2019, the novel human coronavirus (COVID-19) was identified in Wuhan, China and swiftly spread in all nations and territories around the globe. There is much debate about the major route of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmissions. So, more evidence is required to determine the potential pathway of transmission of SARS-CoV-2 including airborne transmission. Therefore, we examined the potential aerosol transmission of the virus through hospital wards indoor air by confirmed COVID-19 patients on May 7, 2020. In order to capture airborne SARS-CoV-2, the liquid impinger biosampler was used to take fourteen air samples in different wards of the indoor air of the hospital. The specific primer and probe real-time reverse transcriptase-polymerase chain reaction (RT-PCR) were applied to detect viral genomes of the SARS-CoV-2 virus in positive air samples. Accordingly, we found two positive air samples (in the ICU) out of 14 ones taken from different wards with confirmed COVID-19 patients. The results revealed the possibility of airborne transmission of SARS-CoV-2 though more studies are required to determine the role of actual mechanisms such as cough, sneeze, normal breathing and speaking in the emission of airborne size carrier aerosols. Likewise, more quantitative analyses are needed to estimate airborne viability of SARS-CoV-2 in the carrier aerosols.


Subject(s)
Air Pollution, Indoor , Coronavirus Infections , Pandemics , Pneumonia, Viral , Severe acute respiratory syndrome-related coronavirus , Betacoronavirus , COVID-19 , China , Coronavirus Infections/epidemiology , Humans , Pneumonia, Viral/epidemiology , SARS-CoV-2
5.
Virology ; 548: 1-5, 2020 09.
Article in English | MEDLINE | ID: mdl-32530808

ABSTRACT

INTRODUCTION: During the recent months, COVID-19 has turned to a global crisis claiming high mortality and morbidity among populations. Despite the high prevalence of the disease, it has currently no definitive treatment. We here reported the effects of intravenous immunoglobulin (IVIG) administration in severely ill COVID-19 patients diagnosed based on PCR and radiology tests. CASE PRESENTATION: Five severely ill COVID-19 patients in whom standard treatments failed were administrated with IVIG which prevented the deterioration of clinical symptoms. All the patients were treated with high-dose IVIG (0.3-0.5 g/kg) for 5 consecutive days so that no patient would receive lower than 25 g of the drug. All the patients showed a desirable therapeutic response and were discharged from the hospital with a stable clinical condition after being recovered. CONCLUSION: Treatment with IVIG at the therapeutic dose of 0.3-0.5 g/kg can improve the clinical condition and O2 saturation and prevent the progression of pulmonary lesions in COVID-19 patients with severe symptoms in whom standard treatments have failed.


Subject(s)
Betacoronavirus , Coronavirus Infections/therapy , Immunoglobulins, Intravenous/therapeutic use , Pneumonia, Viral/therapy , Aged , COVID-19 , Coronavirus Infections/drug therapy , Disease Progression , Female , Humans , Immunoglobulins, Intravenous/administration & dosage , Male , Middle Aged , Pandemics , Pneumonia, Viral/drug therapy , SARS-CoV-2 , Treatment Outcome , COVID-19 Drug Treatment
SELECTION OF CITATIONS
SEARCH DETAIL
...